Arete Upgrades Meta to Buy, $735 Price Target

Analyst: Rocco Strauss 3 min read Reproduced verbatim
Rating
Buy
from Neutral
Target
$735
Outcome
Reached
on September 21, 2026
Arete Research and Meta logos

What the analyst said

Meta Platforms | Arete


Analyst
Rocco Strauss

Date
June 2, 2026

12-Month Price Target
$735.00

Upside/Downside Implied
Upside 22.5%

Rating
Buy

Arete analyst Rocco Strauss upgraded Meta Platforms Inc. (NASDAQ: META) from Neutral to Buy with a price target of $735.00.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

META trades at $607. The 33 analysts who set a target in the last 3 months range from $650 to $1,000, with a median of $860. This $735 target is 15% below the median.

Since the note META has moved +1% (from $600). 12-month window: day 153 of 365, closes on June 2, 2027.

Track record

This call✓ Target reached on September 21, 2026, 4 months after the note.

Firm track recordToo early to score Arete Research: price targets are 12-month calls and fewer than 5 of its targets are a year old. 3 of its 6 open targets have already been reached. How we score

Arete Research on Meta

Arete Research price targets on Meta

2 calls from December 4, 2025 to June 2, 2026. The target went from $718 to $735 (+2%). The rating stayed Buy.

Arete Research targetMETA share price
  1. June 2, 2026 This noteTarget raised from $718 (+2%)Buy$735
  2. December 4, 2025Earliest call shownBuy$718
Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.